S100A8 and S100A9 are Associated with Doxorubicin-induced Cardiotoxicity in the Heart of Diabetic Mice

S100A8 and S100A9 are Associated with Doxorubicin-induced Cardiotoxicity in the Heart of Diabetic Mice

Cardiomyopathy is a clinical problem that occurs in the hearts of type 2 diabetic patients as well as cancer patients undergoing doxorubicin chemotherapy. The number of diabetic cancer patients is increasing but surprisingly the cardiac damaging effects of doxorubicin, a commonly used chemotherapeut...

Full description

Bibliographic Details
Main Authors: Xiao Pei, Bjorn Tam, Thomas Sin, Feng Wang, Benjamin Yung, Lawrence Wing Chi Chan, SC Cesar Wong, Michael Ying, Christopher Lai, Parco M Siu
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-08-01
Series:Frontiers in Physiology
Subjects:
Doxorubicin
cardiotoxicity
type 2 diabetes mellitus
S100A9
S100A8
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphys.2016.00334/full

Similar Items

Similar Items